Family Office Of America (FOFA) Cash & Current Investments (2021 - 2026)
Family Office Of America's (FOFA) quarterly Cash & Current Investments came in at $343220.0 in Q1 2026, down 39.28% year-on-year from $565222.0 in Q1 2025, and up 120.3% quarter-over-quarter from $155798.0 in Q4 2025.
Family Office Of America (FOFA) Cash & Current Investments (2021 - 2026) Analysis & Trends
Family Office Of America has disclosed Cash & Current Investments across 6 years of filings, most recently posting $343220.0 for Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $343220.0, down 39.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $343220.0 (down 39.28% YoY), and the FY2025 annual result was $155798.0, up 1046.75% from the prior year.
- Cash & Current Investments came in at $343220.0 for Q1 2026 at Family Office Of America, up from $155798.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $827598.0 in Q3 2025 to a low of $2431.0 in Q4 2023.
- The 5-year median for Cash & Current Investments is $123858.0 (2022), against an average of $230941.4.
- Across the five-year window, Cash & Current Investments plunged 98.04% in 2023 and soared 1672.01% in 2025, its largest moves.
- Family Office Of America's Cash & Current Investments stood at $123858.0 in 2022, then slumped by 98.04% to $2431.0 in 2023, then surged by 458.86% to $13586.0 in 2024, then surged by 1046.75% to $155798.0 in 2025, then soared by 120.3% to $343220.0 in 2026.
- The last three Cash & Current Investments figures came in at $343220.0 (Q1 2026), $155798.0 (Q4 2025), and $827598.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Family Office Of America | - | - | 783,126.00 | 343,220.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 343,220.00 |
| Dec 31, 2025 | 155,798.00 |
| Sep 30, 2025 | 827,598.00 |
| Jun 30, 2025 | 585,273.00 |
| Mar 31, 2025 | 565,222.00 |
| Dec 31, 2024 | 13,586.00 |
| Sep 30, 2024 | 46,704.00 |
| Jun 30, 2024 | 62,956.00 |
| Mar 31, 2024 | 90,571.00 |
| Dec 31, 2023 | 2,431.00 |
| Sep 30, 2023 | 55,331.00 |
| Jun 30, 2023 | 78,627.00 |
| Mar 31, 2023 | 70,105.00 |
| Dec 31, 2022 | 123,858.00 |
| Sep 30, 2022 | 225,952.00 |
| Jun 30, 2022 | 280,287.00 |
| Mar 31, 2022 | 398,485.00 |
| Dec 31, 2021 | 582,284.00 |
| Sep 30, 2021 | 703,921.00 |
| Jun 30, 2021 | 1.06 Mn |